Narayana Health Care
  • Cardiology
  • Gastroenterology
  • Nephrology
  • Neurology
  • Oncology
  • Book An Appointment
    • Video Consultation
    • Physical Consultation
Narayana Health Care
  • Cardiology
  • Gastroenterology
  • Nephrology
  • Neurology
  • Oncology
  • Book An Appointment
    • Video Consultation
    • Physical Consultation
Home > Blog > Breast Cancer > Advances in Breast Cancer diagnosis and treatment
Breast Cancer

Advances in Breast Cancer diagnosis and treatment

by Narayana Health October 15, 2020
written by Narayana Health October 15, 2020
Advances in Breast Cancer diagnosis and treatment | Narayana Health

Breast cancer remains one of the two most common types of cancer in the world. It’s the fifth-leading cause of cancer-related deaths annually.

But there is a reason for hope.

Research has yielded a number of exciting developments in breast cancer diagnosis and treatment that will improve the lives of breast cancer patients for years to come.

Node preservation reduces lymphedema cases

Axillary lymph nodes used to be removed from the armpit routinely during breast cancer surgery to test for metastasis. This caused chronic pain, numbness and lymphedema in about 1 in 5 patients. But studies have shown that many of those nodes can be preserved — without compromising long-term survival rates.

Sentinel node mapping lets surgeons identify which lymph nodes are most likely to be affected by a tumour. Targeted axillary dissection allows surgeons to potentially preserve nodes that once tested positive for cancer, but reverted to negative status after chemotherapy or another treatment. In both cases, if tests come back negative for cancer on the first few nodes taken out, the remaining nodes can be left alone. That means fewer complications and fewer side effects for our breast cancer patients.

About 15-20% of patients developed lymphedema when all nodes were routinely removed, but when sentinel node mapping is done, that figure drops to 5%. And the chance of a recurrence in the axilla is quite small using this strategy at the same time it improves patients’ quality of life.

Genomic testing minimizes chemotherapy exposure

For years, many patients got chemotherapy as a part of their breast cancer treatment. But a study in the New England Journal of Medicine showed that chemotherapy wouldn’t benefit up to 85% of patients over age 50 whose breast cancer was HR+, HER- and had not spread to any lymph nodes.

The study involved a genomic assay (or OncotypeDX test) that looked at the expression of 21

different genes in a patient’s primary tumour. A tumour’s gene expression pattern shows whether or not it will be responsive to chemotherapy, or whether endocrine therapy alone (such as tamoxifen) would be a better choice. The study showed that patients scoring in the

low-to-mid-risk range could safely skip chemotherapy, avoiding hair loss, neuropathy, weight loss and other side effects that often come with it.

Before that study, we didn’t know if it was safe to omit chemotherapy, but now, we know we can get the same overall outcome by doing less. So, we’re minimizing overtreatment. And it has totally changed how we practice medicine.

Better identification of hereditary cancer syndromes

A number of genetic mutations — such as BRCA1 and BRCA2 — are already known to increase a person’s risk of developing certain cancers, including breast cancer. But now, next-generation gene sequencing techniques are helping researchers identify other hereditary cancer syndromes that can put people at risk.

We always knew there were certain families with strong histories of cancer, But by analyzing

blood and saliva, we can reach out to other family members earlier – both to provide preventive care through enhanced screenings and to identify existing cancers.

An oral option for targeted therapy

 Until recently, PARP inhibitors were used primarily to treat ovarian cancer. They work by preventing damaged cancer cells with specific genetic mutations from repairing themselves. Today, this targeted therapy is being used to treat breast cancer successfully, too.

DNA has multiple ways to repair itself, so when someone has a genetic mutation that closes one pathway, their DNA uses another one instead. PARP inhibitors block those escape routes, so cancer cells can’t grow and divide.

Breast cancer is linked to fewer mutations than ovarian cancers, but PARP inhibitors can still exploit them. Clinical trials have shown improvements in progression-free survival for patients with an inherited BRCA gene mutation and metastatic breast cancer. There is an overall improvement in the quality of life of patients who received these oral drugs, as opposed to those patients who received chemotherapy.

Patients now have an oral option in this class of drugs, Early results indicate that some patients will still have a complete response: meaning no cancer can be found in their breasts at the time of surgery.

New drug combination makes estrogen-blocking agents more effective 

Patients with hormone receptor-positive breast cancers are often prescribed estrogen-reducing agents such as letrozole and anastrozole to starve the tumours. Now, studies show that those patients do even better when hormone therapy is combined with CDK4/6 inhibitors, which prevent cancer cells from dividing.

Three different CDK4/6 inhibitors have been approved by the U.S. FDA (abemaciclib, palbociclib and ribociclib). When combined with hormone therapy, all three CDK4/6 inhibitors have shown immense improvement in progression-free survival in patients with stage IV breast cancer. So, this has become the standard of care in nearly all metastatic HR+ breast cancer patients for first-line treatment. It’s a big change in how we treat breast cancer.

The next generation of monoclonal antibodies

 Trastuzumab (Herceptin) is a monoclonal antibody that has been used to treat HER2+ breast cancer patients since the 1990s. It works by targeting the HER2 receptor and preventing cancer growth. Some breast cancers express too much HER2 protein, triggering the cells to multiply very rapidly.

Other monoclonal antibodies (such as pertuzumab/Perjeta) have since been developed. Today, this targeted therapy has gotten even more advanced. T-DM1 (Kadycla), an antibody-drug combination, has been approved for use in the treatment of HER2+ breast cancers.

Antibody-drug combinations work like a “smart bomb,” delivering chemotherapy directly to cancer cells by attaching to their HER2+ receptors.

Targeted therapies have transformed our approach to HER2+ breast cancers, and offer an opportunity to cure stage IV breast cancer in certain patients. So, monoclonal antibodies have been a big game-changer.

Dr. Rashmi Sharma, Senior Consultant- Surgical Oncology (Breast Specialist), Narayana Superspeciality Hospital Gurugram

0 comment
0
FacebookTwitterPinterestWhatsapp
previous post
Why is breast biopsy absolutely essential for cancer treatment?
next post
10 Foods To Eat For Your Heart

You may also like

Know your risk factors for breast cancer

January 5, 2021

Why is breast biopsy absolutely essential for cancer...

October 14, 2020

Be your own kind of beautiful even with...

October 10, 2020

Creating Awareness – Busting Myth and Facts of...

October 9, 2020

Detection of Breast Cancer – Increasing the odds

July 27, 2020

Hereditary Breast-Ovarian Cancer Syndrome (HBOC)

May 27, 2020

Breast Lump

May 19, 2020

Importance of Regular Screening in Women at High...

February 27, 2020

Her breast: Her decision !!

February 4, 2020

Molecular Classification of Breast Cancer: A New Way...

January 25, 2020

About NH

Narayana Health

Narayana Health is headquartered in Bengaluru, India, and operates a network of hospitals across the country, with a particularly strong presence in the southern state of Karnataka and eastern India, as well as an emerging presence in northern, western and central India. Our first facility was established in Bengaluru with approximately 225 operational beds and we have since grown to 23 hospitals, 7 heart centres, 19 primary care facilities across India and an international hospital in the Cayman Islands.

Keep In Touch

Facebook Twitter Instagram Linkedin Youtube Telegram

Tell us your Medical Query

[recaptcha]


Popular Posts

  • 1

    Coronavirus Testing – How to Test for Coronavirus? – Different Types of...

    March 13, 2020
  • 2

    Boosting your Immune System against Coronavirus: How to minimize the risk of infection?

    April 2, 2020
  • 3

    Know about proper usage, disposal and reuse of mask

    April 6, 2020
  • 4

    अल्सर क्या होता है?

    July 18, 2019

Categories

  • Aids (3)
  • Blood Pressure (4)
  • Bone marrow transplant (10)
  • Breast Cancer (28)
  • Cancer (28)
  • Cardiac Surgery (23)
  • Cardiology (106)
  • Coronavirus (93)
  • Dental Sciences (1)
  • Dermatology (7)
  • Diabetes (33)
  • E. N. T – Paediatric (5)
  • E. N. T. (3)
  • ECMO (1)
  • Endocrinology (3)
  • Gastroenterology (19)
  • General Health (31)
  • General Surgery (3)
  • Gynaecology (23)
  • Haematology (4)
  • Healthy Life (1)
  • heart (4)
  • Hepatology (11)
  • Infectious Diseases (2)
  • Kidney (5)
  • Liver (26)
  • medical oncology (1)
  • Mental Health (2)
  • Narayanahealth (222)
  • Nephrology (19)
  • Neurology (72)
  • Neurosurgery (23)
  • News (11)
  • NH services (6)
  • Nutrition and diet (9)
  • Oncology (61)
  • Organ Donation (1)
  • Orthopaedics (62)
  • Paediatric Cardiology (8)
  • Paediatric Surgery (3)
  • Paediatrics (48)
  • Pain & Palliative Care (3)
  • Pregancy (3)
  • Psychology (3)
  • Pulmonology (13)
  • Radiation Oncology (3)
  • Rheumatology (3)
  • Services (6)
  • Spine Surgery (17)
  • Stroke (4)
  • Swine Flu (1)
  • Transplant (1)
  • Urology (21)
  • Vascular Surgery (9)

Follow us

QUICK LINKS

Find a Doctor

Book an Appointment

Make an Enquiry

Feedback

Hospitals

Blogs

Privilege card

Heart Rhythm Disorder

NH CARES

Hernia

Lung Cancer

Brain Tumour

Liver Cancer

Heart Attack

Urinary Problems

Heart Transplant

Kidney Transplant

Bone Marrow Transplant

Pulmonary Hypertension

CENTRES OF EXCELLENCE

Liver Transplant & HPB Surgery

Cardiology

Cardiac Surgery

Neurology

Neurosurgery

Orthopaedics

Robotic Surgery

Vascular Surgery

Nephrology

Radiation Oncology

MEDICAL PROFESSIONALS

Academics

Clinical Research

NH Colleges

SUBSCRIBE TO OUR NEWSLETTER

Subscribe to our Newsletter for new blog posts, tips & new photos. Let's stay updated!

About Narayana Health

|

Stakeholder Relations

|

News & Media Relations

|

Awards and Accreditations

|

Leadership

|

Careers

|

CSR

|

Sitemap

© Narayana Hrudayalaya Ltd | All rights reserved
NPPA Implant Pricing     Terms & Conditions     Privacy Policy     Disclaimer

Book Online Consultation